zileuton


Also found in: Medical, Wikipedia.

zi·leu·ton

 (zī-lo͞o′tn)
n.
A drug that inhibits leukotriene formation, used to treat asthma.

[(ben)z(oth)i(ene), one of its components + leu(ko)t(riene) + -on.]
References in periodicals archive ?
Taken orally, zileuton inhibits the 5-LO enzyme, which would otherwise catalyze the formation of leukotrienes from arachidonic acid.
Saryan and his associates at Lahey use involves systematic pretreatment with antihistamines, leukotriene-modifying drugs such as montelukast or zileuton, and in one case, prednisone.
She had been treated with carvedilol, lisinopril, zileuton, and inhaled corticosteroids.
an associate professor of pharmacology in Temple's School of Medicine, the researchers tested the drug Zileuton, an inhibitor of 5-lipoxygenase typically used to treat asthma, in a transgenic mouse model of Alzheimer's disease.
In their current study, led by Domenico Pratico, an associate professor of pharmacology in Temple's School of Medicine, the researchers tested the drug Zileuton, an inhibitor of 5-lipoxygenase typically used to treat asthma, in a transgenic mouse model of Alzheimer's disease.
The FDA, which issued the call in mid June, said the reported neuropsychiatric events included cases of agitation, aggression, anxiety, dream abnormalities and hallucinations, depression, insomnia, irritability, restlessness, suicidal ideation and behavior, and tremor in patients using montelukast (Singulair), zafirlukast (Accolate), and zileuton (Zyflo, Zyflo CR).
In March 2007, Critical Therapeutics and DEY entered into an agreement for the co-promotion of ZYFLO CR(TM) and ZYFLO(R), the immediate-release formulation of zileuton.
2001) and as effective as the synthetic 5-lipoxygenase inhibitor zileuton (Thomet et al.
The other leukotriene-modifier zileuton, a 5-lipoxygenase inhibitor, must be administered four times per day and has the potential for hepatic toxicity.
Zileuton and zafirlukast should be avoided during pregnancy because they are teratogenic or fetotoxic in animals.
The leukotriene synthesis inhibitor zileuton and the leukotriene receptor antagonist zafirlukast have been shown to produce subjective and objective improvements in patients with mild to moderate asthma.
Zileuton and zafirlukast are a more recent type of long-term-control medicine.